<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230513058170N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-06-20</date_registration>
      <primary_sponsor>Zahedan University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effect of pomegranate skin mouthwash on oral hygiene and bacterial colonization of oral and tracheal intubated patients admitted to the intensive care units(ICUs)</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of pomegranate skin mouthwash on oral hygiene and bacterial colonization of oral and tracheal intubated patients admitted to the intensive care units(ICUs)</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-05-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/70132</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: Sampling is based on the entry criteria and is selected in an available manner, and then the random number table will be used for the random allocation of patients in such a way that for each person from the sample, a point will be determined on the random number table using a pen tip, and then We move from right to left and a number will be selected from the table of random numbers. If even and zero digits are obtained, the person will be in the intervention group, and if odd numbers are obtained, the person will be placed in the control group, Blinding description: Single-blind clinical trial - in such a way that blinding will be done for the laboratory expert , for this purpose, the samples collected by the researcher will be provided to the laboratory in the same containers with the same label and code, and the laboratory official will not be aware of the type of intervention.</study_design>
      <phase>1-2</phase>
      <hc_freetext>Investigating the effect of pomegranate peel extract mouthwash on oral hygiene.</hc_freetext>
      <i_freetext>Intervention 1: The intervention group-preparation of pomegranate peel extract from Adonisgol Daru Company-Tehran, has an international approval and certificate. Pomegranate peel extract with a concentration of 0.2% is administered twice a day at an interval of 12 hours (9-21) for four days, before the intervention. The entire surface of the mouth, gums, tongue, pharynx, and tooth surfaces is carefully brushed with a soft children'stoothbrush, and the remaining secretions in the throat and mouth are suctioned with a sterile green Nalaton catheter in less than 30 seconds. . The whole process of cleaning the mouth and washing takes 6 minutes. Intervention 2: Control group: chlorhexidine mouthwash 0.2% - according to the routine of the ICU department using 0.2% chlorhexidine mouthwash, which is done twice a day every 12 hours (9-21) for four days, before the intervention. The entire surface of the mouth, gums, tongue, pharynx, and tooth surfaces is carefully brushed with a soft children'stoothbrush, and the remaining secretions in the throat and mouth are suctioned with a sterile green Nalaton catheter in less than 30 seconds. . The whole process of cleaning the mouth and washing takes 6 minutes.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Marzieh Saravani Pak</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.34 JamJamStreet62 ThreeAlley</address>
        <city>Zahedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9814745413</zip>
        <telephone>+98 54 3328 9758</telephone>
        <email>msaravanipak@gmail.com</email>
        <affiliation>Zahedan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Mehdi Rizvani Amin</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Behdasht Street-Mashahir Bivd-School of Nursing and Midwifery</address>
        <city>Zahedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>05433442481</zip>
        <telephone>+98 54 3344 2481</telephone>
        <email>Mehdi.rezvaniamin@gmail.com</email>
        <affiliation>Zahedan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Intubated patients admitted to the special care department of teaching hospitals in Zahedan
- Patients with a tracheal tube and a level of consciousness of 3 to 7 on the GCS scale
2- Age 18 to 65 years
3- 24 hours have passed since the admission or hospitalization of the patient
4- Having natural teeth in the patient
5- Not having a history of allergy to pomegranate
6- Absence of a specific lesion in the mouth
7- The patient should not have radiotherapy experience
8- Willingness of the patient's legal guardian to continue participating in the study
9- Obtaining oral health evaluation checklist score less than 16.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>- Airway damage during intubation
2- Pneumonia as an inpatient diagnosis
3- History of allergy to used mouthwash, asthma, allergic rhinitis and skin inflammation
4- Signs of sensitivity to mouthwash, such as redness, urticaria, and sores inside the mouth
5- Transfer of the patient from ICU or his death before the completion of the research</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The intervention group-preparation of pomegranate peel extract from Adonisgol Daru Company-Tehran, has an international approval and certificate. Pomegranate peel extract with a concentration of 0.2% is administered twice a day at an interval of 12 hours (9-21) for four days, before the intervention. The entire surface of the mouth, gums, tongue, pharynx, and tooth surfaces is carefully brushed with a soft children'stoothbrush, and the remaining secretions in the throat and mouth are suctioned with a sterile green Nalaton catheter in less than 30 seconds. . The whole process of cleaning the mouth and washing takes 6 minutes.</i_keyword>
      <i_keyword>Control group: chlorhexidine mouthwash 0.2% - according to the routine of the ICU department using 0.2% chlorhexidine mouthwash, which is done twice a day every 12 hours (9-21) for four days, before the intervention. The entire surface of the mouth, gums, tongue, pharynx, and tooth surfaces is carefully brushed with a soft children'stoothbrush, and the remaining secretions in the throat and mouth are suctioned with a sterile green Nalaton catheter in less than 30 seconds. . The whole process of cleaning the mouth and washing takes 6 minutes.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The bacterial colonization status of the tracheal tube of intubated patients. Timepoint: on the first day (before admission of patients) and on the fourth day in the ICU department. Method of measurement: Beck's measurement scale - oral mucosal plaque score - culture from Score obtained from the scale (MPS) = 2-4 a unacceptable MPS = 7-8 weak, the score received every day on the scale (BOAS). Number 5 no disorder, 6-10 mild disorder, 11-15 moderate disorder, 16-20 severe disorde،Cultivation on the first day (before admission of patients) and the fourth day in the ICU departmentmouth and tracheal tube.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Zahedan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-05-14</approval_date>
        <contact_name>Ethics Committee of Zahedan University of Medical Sciences</contact_name>
        <contact_address>Zahedan, 62 Jam Jam St., Milan II, on the right side of the third door Zahedan Sistan-va-Balouchestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
